Rinvoq ER 45 MG tablet UU 28S
Ended Awarded
- Contract number
- SPE2DX25F6TWM
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $33,896
Award facts
- Contract value 100% obligated
- $33,896.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The U.S. Department of Defense's Medical Supply Chain awarded a delivery order valued at $33,896.40 to AmerisourceBergen Drug Corp for the supply of RINVOQ ER 45 mg tablets (28-count units) with an ultimate completion date of August 26, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical, valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare systems.
RINVOQ (upadacitinib) is a Janus kinase inhibitor used primarily for the treatment of rheumatoid arthritis and other immune-mediated inflammatory conditions. AmerisourceBergen's role as a prime vendor under the DLA contract enables it to supply a broad range of pharmaceutical products and medical commodities to support Defense Health Agency programs and other federal healthcare systems worldwide. The company's federal contract portfolio demonstrates consistent capability in meeting defense procurement requirements through open competition, with previous awards covering diverse therapeutic areas including specialty medications, vaccines, and medical devices across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DX25F6TWM?
SPE2DX25F6TWM was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on August 25, 2025.
How much is contract SPE2DX25F6TWM worth?
The government has obligated $33,896 on SPE2DX25F6TWM.
Is contract SPE2DX25F6TWM an order under another contract?
Yes. SPE2DX25F6TWM is a delivery order under SPE2DX15D1053, an indefinite delivery contract.
Was contract SPE2DX25F6TWM competed?
The extent of competition for SPE2DX25F6TWM was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award